Australia Cancels Order for CSL Vaccine as Trial Stumbles
- CSL vaccine produced false HIV positive results in trials
- Government orders more AstraZeneca, Novavax vaccines
CSL staff work in the lab in Melbourne, Australia, on Nov. 8.
Photographer: Darrian Traynor/Getty ImagesThis article is for subscribers only.
Australia canceled an order for 51 million doses of a Covid-19 vaccine being developed by CSL Ltd. and the University of Queensland after trials ran into difficulties.
The government said Friday it’s replacing most of the CSL doses with more purchases of other planned vaccines. Australia has ordered an extra 20 million shots being developed by the University of Oxford and AstraZeneca Plc, and 11 million more Novavax Inc. doses, the government said.